Articles

1. The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights

   • Kathy A. Fraser

   Meeting Report 21 August 2023 Pages: 849 - 851

2. Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation

   • Andrea Chiricozzi
   • Michela Ortoncelli
   • Ketty Peris

   Correction Open access 19 August 2023 Pages: 963 - 964

3. Antifungal Resistance, Susceptibility Testing and Treatment of Recalcitrant Dermatophytosis Caused by Trichophyton indotineae: A North American Perspective on Management

   • Aditya K. Gupta
   • Shruthi Polla Ravi
   • Wayne L. Bakotic

   Review Article 08 August 2023 Pages: 927 - 938

   

4. Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis

   • Sophia Ly
   • Priya Manjaly
   • Arash Mostaghimi

   Systematic Review 18 July 2023 Pages: 875 - 893

   

5. Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies

   • Christopher J. Fay
   • Samantha Jakuboski
   • Nicole R. LeBoeuf

   Review Article 03 July 2023 Pages: 765 - 785

   

6. Characteristics and Burdens of Disease in Patients from Beijing with Generalized Pustular Psoriasis and Palmoplantar Pustulosis: Multicenter Retrospective Cohort Study Using a Regional Database

   • Hai-Meng Wang
   • Jia-Ming Xu
   • Hong-Zhong Jin

   Original Research Article 29 June 2023 Pages: 991 - 1002

   

7. Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study

   • Amit Garg
   • Yvonne Geissbühler
   • Alexa B. Kimball

   Original Research Article Open access 28 June 2023 Pages: 977 - 990

   

8. Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”

   • Chia-Ling Yu
   • Po-Yi Chou
   • Ching-Chi Chi

   Letter to the Editor 27 June 2023 Pages: 855 - 858

   

9. Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”

   • Shurong Chen
   • Yi Chen

   Letter to the Editor 27 June 2023 Pages: 853 - 854

10. Dupilumab-Associated Arthritis: A Dermatology-Rheumatology Perspective

    • Michael J. Woodbury
    • Jeffrey S. Smith
    • Joseph F. Merola

    Current Opinion 22 June 2023 Pages: 859 - 864

    

11. Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials

    • Michael Sticherling
    • Arjen F. Nikkels
    • Deborah Keefe

    Original Research Article Open access 21 June 2023 Pages: 821 - 835

12. Do Biologic Treatments for Psoriasis Lower the Risk of Psoriatic Arthritis? A Systematic Review

    • Anna Aronovich
    • Ilya Novikov
    • Lev Pavlovsky

    Systematic Review 21 June 2023 Pages: 865 - 873

    

13. Climate Change, Skin Health, and Dermatologic Disease: A Guide for the Dermatologist

    • Annika Belzer
    • Eva Rawlings Parker

    Review Article 20 June 2023 Pages: 577 - 593

    

14. Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”

    • Heli Patel
    • Steven R. Feldman

    Commentary 20 June 2023 Pages: 497 - 498

15. Atopic Dermatitis Across Shades of Skin

    • Victor L. Quan
    • Taylor Erickson
    • Raj Chovatiya

    Review Article 19 June 2023 Pages: 731 - 751

    

16. Baricitinib: A Review in Severe Alopecia Areata

    • Simon Fung
    • Matt Shirley

    Adis Drug Evaluation 16 June 2023 Pages: 661 - 668

    

17. Targeting Inflammation in Acne: Current Treatments and Future Prospects

    • Sebastian Cruz
    • Natalia Vecerek
    • Nada Elbuluk

    Leading Article Open access 16 June 2023 Pages: 681 - 694

18. Capturing the Diversity of Dermatology—What’s in a Name?

    • Taylor Erickson
    • Karishma Daftary
    • Raj Chovatiya

    Current Opinion 16 June 2023 Pages: 675 - 680

    

19. Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation

    • Andrea Chiricozzi
    • Michela Ortoncelli
    • Ketty Peris

    Original Research Article Open access 15 June 2023 Pages: 953 - 961

    

20. Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet’s Syndrome

    • Philip J. Mease
    • Gülen Hatemi
    • Linda Stein Gold

    Original Research Article Open access 14 June 2023 Pages: 809 - 820

    

21. Global Incidence, Mortality, Risk Factors and Trends of Melanoma: A Systematic Analysis of Registries

    • Junjie Huang
    • Sze Chai Chan
    • Martin C. S. Wong

    Original Research Article 10 June 2023 Pages: 965 - 975

    

22. Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial

    • Elaine C. Siegfried
    • Michael J. Cork
    • Annie Zhang

    Original Research Article Open access 10 June 2023 Pages: 787 - 798

    

23. Association Between the Use of Topical Calcineurin Inhibitors and the Risk of Cancer Among Patients with Atopic Dermatitis: A Nationwide, Population-Based, Retrospective Cohort Study

    • Hao-Hsin Huang
    • Dereck Shen
    • Chia-Yu Chu

    Original Research Article 06 June 2023 Pages: 799 - 808

    

24. Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis

    • Diana Bernardo
    • Thomas Bieber
    • Tiago Torres

    Review Article Open access 02 June 2023 Pages: 753 - 764

    

25. Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study

    • Tadashi Terui
    • Yukari Okubo
    • Masamoto Murakami

    Original Research Article Open access 26 May 2023 Pages: 837 - 847

    

26. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial

    • Eric L. Simpson
    • Jonathan I. Silverberg
    • Michael J. Cork

    Original Research Article Open access 22 May 2023 Pages: 609 - 621

    

27. Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review

    • Jonathan K. Hwang
    • Jose W. Ricardo
    • Shari R. Lipner

    Systematic Review 20 May 2023 Pages: 695 - 720

    

28. Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials

    • Jonathan I. Silverberg
    • Charles W. Lynde
    • Noah A. Levit

    Publisher Correction Open access 17 May 2023 Pages: 673 - 673

29. Eosinophil–Lymphocyte Ratio, Eosinophil–Neutrophil Ratio, and Eosinophil–Monocyte Ratio in Chronic and Severe Urticaria

    • Sarah Weissmann
    • Nitzan Burrack
    • Amir Horev

    RESEARCH LETTER 17 May 2023 Pages: 669 - 671

30. Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials

    • Linda Stein Gold
    • Diamant Thaçi
    • Marjolein de Bruin-Weller

    Original Research Article Open access 17 May 2023 Pages: 595 - 607

31. Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study

    • Lawrence F. Eichenfield
    • Richard G. Gower
    • John Werth

    Original Research Article Open access 15 May 2023 Pages: 623 - 635

    

32. Automated Facial Acne Lesion Detecting and Counting Algorithm for Acne Severity Evaluation and Its Utility in Assisting Dermatologists

    • Dong Hyo Kim
    • Sukkyu Sun
    • Dae Hun Suh

    Original Research Article 09 May 2023 Pages: 649 - 659

    

33. Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management

    • Rose Parisi
    • Hemali Shah
    • Roni P. Dodiuk-Gad

    Review Article 08 May 2023 Pages: 557 - 575

    

34. Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy

    • Eftychia Chatziioannou
    • Ulrike Leiter
    • Teresa Amaral

    Original Research Article Open access 04 May 2023 Pages: 453 - 467

    

35. Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions

    • Dennis Niebel
    • Luka de Vos
    • Jörg Wenzel

    Review Article Open access 04 May 2023 Pages: 521 - 540

    

36. Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis

    • Bertrand ShengYang Lian
    • Judy H. Ha
    • Haur Yueh Lee

    Original Research Article 03 May 2023 Pages: 637 - 647

    

37. Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists

    • Aditya K. Gupta
    • Mesbah Talukder
    • Vincent Piguet

    Review Article 27 April 2023 Pages: 541 - 556

    

38. Author’s Reply to Parvathaneni et al. Comment on: “Methotrexate Cutaneous Ulceration: A Systematic Review of Cases”

    • Ronald Berna
    • Meghan Quinlan
    • Emily Baumrin

    Letter to the Editor 17 April 2023 Pages: 491 - 492

39. Comment on: “Methotrexate Cutaneous Ulceration: A Systematic Review of Cases”

    • Aarthi Parvathaneni
    • Adam Olesen
    • Dayna Diven

    Letter to the Editor 17 April 2023 Pages: 487 - 489

    

40. Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”

    • Philip R. Cohen

    Letter to the Editor 14 April 2023 Pages: 485 - 486

41. Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review

    • Adam Daunton
    • Matthew Harries
    • Andrew Messenger

    Systematic Review 13 April 2023 Pages: 513 - 520

    

42. Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis

    • Chia-Ling Yu
    • Po-Yi Chou
    • Ching-Chi Chi

    Systematic Review 03 April 2023 Pages: 721 - 730

    

43. Blue Nail Discoloration: Literature Review and Diagnostic Algorithms

    • Jonathan K. Hwang
    • Shari R. Lipner

    Review Article 27 March 2023 Pages: 419 - 441

    

44. Correction to: Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis

    • Sheridan M. Hoy

    Correction Open access 24 March 2023 Pages: 495 - 495

45. Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA)

    • Tala B. Shahin
    • Shreya A. Sreekantaswamy
    • Daniel C. Butler

    Review Article 15 March 2023 Pages: 405 - 418

    

46. Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion

    • Emmilia Hodak
    • Larisa Geskin
    • Christiane Querfeld

    Correction Open access 14 March 2023 Pages: 493 - 493

47. Treatment of Recurrent Melanoma Following Adjuvant Therapy

    • Nausicaa Malissen
    • Jean-Jacques Grob

    Leading Article 08 March 2023 Pages: 333 - 341

48. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)

    • Ohsang Kwon
    • Maryanne M. Senna
    • Brett King

    Original Research Article Open access 01 March 2023 Pages: 443 - 451

    

49. Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know

    • Dorothea Terhorst-Molawi
    • Lena Fox
    • Marcus Maurer

    Review Article Open access 22 February 2023 Pages: 397 - 404

50. Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials

    • Jonathan I. Silverberg
    • Charles W. Lynde
    • Noah A. Levit

    Original Research Article Open access 20 February 2023 Pages: 469 - 483